|Articles|January 24, 2023

Elligo Adds AI-Driven Clinical Research Study Technology

Elligo Health Research® has introduced Data^AI Connect, a new data and technology platform that will enable data-driven clinical research. Data^AIConnect creates efficiencies across the clinical study workflow—reducing human error and digesting patient data to accelerate clinical trials.

Trending on Applied Clinical Trials Online

Elligo Adds AI-Driven Clinical Research Study Technology

Related Content

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

Why Rebuilding Patient Pipelines from Scratch for Every Study Has to Stop

Bringing the Voice of Clinical Practice and Patients into Drug Development

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

Trending on Applied Clinical Trials Online

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots

AI-Enabled Systems Medicine: From Digital Promise to Clinical Operating Model

Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment